Neuropeptide-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1172-1178

  Keffel, Susanne ^a   Schmidt, Martina ^a   Bischoff, Angela ^a   Michel, Martin C ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BISINDOLYLMALEIMIDE; CALPHOSTIN C; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; STAUROSPORINE; WORTMANNIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; NEUROTRANSMISSION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ENZYME INHIBITORS; EXTRACELLULAR SPACE; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROPEPTIDE Y; PHOSPHOLIPASE D; PHOSPHOTRANSFERASES; PROTEIN KINASE C; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED;

EID: 0032732354     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Boarder MR (1994) A role for phospholipase D in control of mitogenesis. Trends Pharmacol Sci 15:57-62.
3. 2-Adrenergic stimulation promotes preadipocyte proliferation. Involvement of mitogen-activated protein kinases. J Biol Chem 269:30254-30259.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J Biol Chem 271:22297-22300.
6. 2+ and increases inositol phosphate production in human erythroleukemia cells. Biochem Biophys Res Commun 165:1138-1144.
7. Elitsur Y, Luk GD, Colberg M, Gesell MS, Dosescu J and Moshier JA (1994) Neuropeptide Y (NPY) enhances proliferation of human colonie lamina propria lymphocytes. Neuropeptides 26:289-295.
8. 1-peptide a suitable fluorescence substrate for routine measurements of protein kinase C? Cell Signal 7:635-642.
9. Erlinge D, Brunkwall J and Edvinsson L (1994) Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: Cooperation with noradrenaline and ATP. Regul Pept 50:259-265.
10. Feth F, Rascher W and Michel MC (1992) Neuropeptide Y (NPY) receptors in HEL cells: Comparison of binding and functional parameters for full and partial agonists and a non-peptide antagonist. Br J Pharmacol 105:71-76.
11. Jalava A, Akerman KEO and Heikkilä J (1993) Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an α-, β-, and ζ-protein kinase C-independent pathway. J Cell Physiol 155:301-312.
12. Kasuya Y, Abe Y, Hama H, Sakurai T, Asada S, Masaki T and Goto K (1994) Endothelin-1 activates mitogen-activated protein kinases through two independent signaling pathways in rat astrocytes. Biochem Biophys Res Commun 204: 1325-1333.
13. Kleinschroth J, Hartenstein J, Rudolph C and Schächtele C (1993) Non-glycosidic/ non-aminoalkyl-substituted indolocarbazoles as inhibitors of protein kinase C. Bioorgan Med Chem Lett 3:1959-1964.
14. i-mediated activation of the ras/MAP kinase pathway involves a 100-kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not src nor shc. EMBO J 16:3097-3105.
15. 2-Adrenoceptors in opossum kidney cells couple to stimulation of mitogen-activated protein kinase independent of adenylyl cyclase inhibition. Naunyn-Schmiedeberg's Arch Pharmacol 356:225-232.
16. 2+ flux inhibition as primary mechanism of staurosporine-induced impairment of T cell activation. Eur J Immunol 19:1393-1398.
17. Malarkey K, Chilvers ER, Lawson MF and Plevin R (1995) Stimulation by endothelin-1 of mitogen-activated protein kinases and DNA synthesis in bovine tracheal smooth muscle cells. Br J Pharmacol 116:2267-2273.
18. Mannon PJ and Raymond JR (1998) The neuropeptide Y/peptide YY Y1 receptor is coupled to MAP kinase via PKC and ras in CHO cells. Biochem Biophys Res Commun 246:91-97.
19. 2+ mobilization in HEL-cells. Br J Pharmacol 112:499-504.
20. i3 expression in human erythroleukemia cells. Eur J Pharmacol 348:135-141.
21. Michel MC, Beck-Sickinger AG, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz TW and Westfall TC (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev 50:143-150.
22. Michel MC, Gaida W, Beck-Sickinger AG, Wieland HA, Doods H, Dürr H, Jung G and Schnorrenberg G (1992) Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: Evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol 42:642-648.
23. i-coupled receptors. Eur J Pharmacol 309:87-94.
24. Michel MC, Schlicker E, Fink K, Boublik JH, Göthert M, Willette RN, Daly RN, Hieble JP, Rivier JE and Motulsky HJ (1990) Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro. Am J Physiol 259:E131-E139.
25. Millar BC, Schlüter K-D, Zhou X-J, McDermott BJ and Piper HM (1994) Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am J Physiol 266:C1271-C1277.
26. ++ and inhibits adenylate cyclase in human erythroleukemia cells. Am J Physiol 255:E880-E885.
27. Nakamura M, Sakanaka C, Aoki Y, Ogasawara H, Tsuji T, Kodama H, Matsumoto T, Shimizu T and Noma M (1995) Identification of two isoforma of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J Biol Chem 270:30102-30110.
28. Neary JT (1997) MAPK cascades in cell growth and death. News Physiol Sci 12:286-293.
29. 2 receptor-mediated stimulation of mitogen-activated protein kinase activity. Regul Pept 75/76:207-213.
30. Post GR and Brown JH (1996) G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 10:741-749.
31. Rüegg UT and Burgess GM (1989) Staurosporine, K-252 and UCN-01: Potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 10:218-220.
32. Schmidt M, Voβ M, Thiel M, Bauer B, Grannaβ A, Tapp E, Cool RH, de Gunzburg J, von Eichel-Streiber C and Jakobs KH (1998) Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases. J Biol Chem 273:7413-7422.
33. 1B-adrenergic receptors in the regulation of phospholipase C, protein kinase C, and arachidonic acid production. J Biol Chem 270:11789-11796.
34. Shigeri Y and Fujimoto M (1993) Neuropeptide-Y stimulates DNA synthesis in vascular smooth muscle cells. Neurosci Lett 149:19-22.
35. Ui M, Okada T, Hazeki K and Hazeki O (1995) Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 20:303-307.
36. van Biegen T, Luttrell LM, Hawes BE and Lefkowitz RJ (1996) Mitogenic signaling via G protein-coupled receptors. Endocrine Rev 17:698-714.
37. i2 proteins in renal proximal tubule cells. J Biol Chem 271:574-580.
38. Wahlestedt C and Reis DJ (1993) Neuropeptide Y-related peptides and their receptors - Are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Taxicol 32:309-352.
39. Walton GM, Bertics PJ, Hudson LG, Vedvick TS and Gill GN (1987) A three-step purification procedure for protein kinase C: Characterization of the purified enzyme. Anal Biochem 161:425-437.
40. Whitman M and Cantley L (1988) Phosphoinositide metabolism and the control of cell proliferation. Biochim Biophys Acta 948:327-344.
41. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA and Ji H (1998) Mechanisms of vascular growth-promoting effects of neuropeptide Y: Role of its inducible receptors. Regul Pept 75/76:231-238.
42. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK and Wahlestedt C (1993) Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14:263-268.